Developer docs
API playgroundTry for free, no card

Search company profiles

Informed Genomics

Full company profile

uuid000udz3

Namestring
Informed Genomics
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Informed Genomics is a private biotechnology company headquartered in Birmingham, United Kingdom, focused on earlier diagnosis, personalized treatments, and improved outcomes for cancer patients. The firm operates within the oncology diagnostics and precision medicine space, positioning itself across the cancer care continuum from detection through treatment selection. The company is registered at informedgenomics.com and operates with a headcount of 11-50 employees, placing it in the early-to-mid stage small-cap biotech category typical of UK clinical-stage diagnostics developers and academic spinouts.

Its Birmingham location situates Informed Genomics within a recognized UK life sciences and genomics cluster. However, specific operational details are not documented in the available data: no proprietary product lines, assay platforms, or underlying technology architectures are described; no laboratory certifications, regulatory clearances (such as UKCA, CE-IVD, MHRA, or FDA), or clinical-grade validation milestones are listed; and no management team, founders, or scientific advisory board members are identified.

The company's revenue model, pricing structure, customer base, ownership structure, funding history, and go-to-market approach are all unconfirmed in the input sources, with primary website content inaccessible due to verification and CAPTCHA blocks. This data gap materially limits visibility into commercial traction, capital structure, and strategic positioning, leaving the firm's current stage of development, pipeline status, and market entry progress undetermined from publicly available signals.

Short descriptiontext

Informed Genomics is a Birmingham, UK-based private biotechnology company focused on earlier cancer diagnosis, personalized treatments, and improved patient outcomes through genomic-driven approaches.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBirmingham, United Kingdom
HQ citystring
Birmingham
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
cancer diagnostics, personalized oncology, genomic testing, molecular diagnostics, biomarker analysis
Industry3 codes
PRIMARYHLAAANAA
Genomic Profiling & Sequencing-Based Precision Medicine
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
NAICS code2 codes
  • Medical Laboratories621511
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Medical Laboratories8071
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Cancer Genomics Diagnostics
Cost components3 values
Personnel, Technology or R&D, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Informed Genomics is a biotechnology company that provides genomics-based cancer diagnostics focused on earlier cancer diagnosis and the selection of personalized treatments. Its offering supports clinicians and patients in oncology by combining molecular and genomic testing to inform therapy decisions and improve clinical outcomes.

Differentiator
Functional benefit
Problem solved
No data
Peers10 records
TypeBroad incumbent
Description

Oncology diagnostics leader (Oncotype DX, Cologuard) with strong cancer genomics heritage and US commercial scale. Comparable to Informed Genomics on cancer genomics and earlier diagnosis but operates a fully commercialized franchise.

TypeDirect peer
Description

Genomics company specializing in ImmunoID Next and other cancer genomics products for biopharma and clinicians. Direct peer in oncology genomic profiling, though more biopharma-services oriented.

3Tempus Labs
TypeBroad incumbent
Description

AI-enabled precision medicine company with extensive oncology genomic profiling and data products. Broad incumbent offering comparable cancer molecular testing plus data/analytics that Informed Genomics' personalization thesis would compete against.

TypeBroad incumbent
Description

Roche-owned leader in comprehensive genomic profiling for solid tumors (FoundationOne CDx). Directly comparable to Informed Genomics' oncology genomics profiling mission but operates at vastly greater scale with FDA-approved companion-diagnostic claims.

TypeBroad incumbent
Description

US-based oncology-focused clinical laboratory offering a wide menu of cancer diagnostic tests including NGS profiling. Comparable to Informed Genomics as a cancer-focused diagnostic lab, but at much larger scale and broader test menu.

6Inivata
TypeRegional player
Description

Cambridge, UK-based liquid biopsy company (acquired by NeoGenomics) focused on circulating tumor DNA for cancer treatment selection and monitoring. Closest geography-matched peer to Informed Genomics in the UK oncology genomics space.

TypeDirect peer
Description

Switzerland-based genomics informatics and diagnostics company with cancer testing (including hereditary cancer and solid-tumor applications). Comparable to Informed Genomics on combining NGS and analytics for cancer diagnosis and personalized treatment, with broader European footprint.

TypeDirect peer
Description

US-based liquid-biopsy and tissue genomics company (Guardant360, Guardant Reveal) focused on cancer diagnosis, treatment selection, and recurrence monitoring. Closest direct peer to Informed Genomics' "earlier diagnosis and personalized treatment" positioning for cancer.

TypeEmerging player
Description

UK-based genomics company providing NGS products and services for liquid biopsy and cancer research. Comparable to Informed Genomics as a UK-headquartered emerging player in cancer genomics, though more research-tools oriented.

TypeDirect peer
Description

Provides MI Profile molecular profiling and Caris Assure liquid biopsy for oncology. Directly competes with Informed Genomics on cancer genomic profiling and personalized treatment selection.

Market position
Competitive moat1 record

Each record includes

Type, Details

Key highlights3 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Informed Genomics

Cancer Genomics Diagnosticsinformedgenomics.com

Informed Genomics is a Birmingham, UK-based private biotechnology company focused on earlier cancer diagnosis, personalized treatments, and improved patient outcomes through genomic-driven approaches.

What Informed Genomics does

Informed Genomics is a private biotechnology company headquartered in Birmingham, United Kingdom, focused on earlier diagnosis, personalized treatments, and improved outcomes for cancer patients. The firm operates within the oncology diagnostics and precision medicine space, positioning itself across the cancer care continuum from detection through treatment selection. The company is registered at informedgenomics.com and operates with a headcount of 11-50 employees, placing it in the early-to-mid stage small-cap biotech category typical of UK clinical-stage diagnostics developers and academic spinouts.

Its Birmingham location situates Informed Genomics within a recognized UK life sciences and genomics cluster. However, specific operational details are not documented in the available data: no proprietary product lines, assay platforms, or underlying technology architectures are described; no laboratory certifications, regulatory clearances (such as UKCA, CE-IVD, MHRA, or FDA), or clinical-grade validation milestones are listed; and no management team, founders, or scientific advisory board members are identified.

The company's revenue model, pricing structure, customer base, ownership structure, funding history, and go-to-market approach are all unconfirmed in the input sources, with primary website content inaccessible due to verification and CAPTCHA blocks. This data gap materially limits visibility into commercial traction, capital structure, and strategic positioning, leaving the firm's current stage of development, pipeline status, and market entry progress undetermined from publicly available signals.

Informed Genomics firmographics

Firmographics
Name
Informed Genomics
Website
https://informedgenomics.com
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Short description
Informed Genomics is a Birmingham, UK-based private biotechnology company focused on earlier cancer diagnosis, personalized treatments, and improved patient outcomes through genomic-driven approaches.
Ownership category
akta.pro rank

Informed Genomics industry classification

Industry
Product category
Cancer Genomics Diagnostics
NAICS
Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAAANAA
Genomic Profiling & Sequencing-Based Precision Medicine
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)

Keywords

  • Cancer diagnostics
  • Personalized oncology
  • Genomic testing
  • Molecular diagnostics
  • Biomarker analysis

Where Informed Genomics is headquartered

Location

Headquarters

HQ city
Birmingham
HQ country
United Kingdom
HQ region
Europe

Markets served

Informed Genomics business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations

Informed Genomics product offering

Product offering

Core offering

Informed Genomics is a biotechnology company that provides genomics-based cancer diagnostics focused on earlier cancer diagnosis and the selection of personalized treatments. Its offering supports clinicians and patients in oncology by combining molecular and genomic testing to inform therapy decisions and improve clinical outcomes.

Differentiator

Problem solved

Functional benefit

Companies that use Informed Genomics

Customer profile

Ideal customer profiles1 record

Informed Genomics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Informed Genomics competitors and assessment

Company assessment

Broad incumbents

  • Exact Sciences (Genomic Health): Oncology diagnostics leader (Oncotype DX, Cologuard) with strong cancer genomics heritage and US commercial scale. Comparable to Informed Genomics on cancer genomics and earlier diagnosis but operates a fully commercialized franchise.
  • Tempus Labs: AI-enabled precision medicine company with extensive oncology genomic profiling and data products. Broad incumbent offering comparable cancer molecular testing plus data/analytics that Informed Genomics' personalization thesis would compete against.
  • Foundation Medicine: Roche-owned leader in comprehensive genomic profiling for solid tumors (FoundationOne CDx). Directly comparable to Informed Genomics' oncology genomics profiling mission but operates at vastly greater scale with FDA-approved companion-diagnostic claims.
  • NeoGenomics: US-based oncology-focused clinical laboratory offering a wide menu of cancer diagnostic tests including NGS profiling. Comparable to Informed Genomics as a cancer-focused diagnostic lab, but at much larger scale and broader test menu.

Direct peers

  • Personalis: Genomics company specializing in ImmunoID Next and other cancer genomics products for biopharma and clinicians. Direct peer in oncology genomic profiling, though more biopharma-services oriented.
  • SOPHiA Genetics: Switzerland-based genomics informatics and diagnostics company with cancer testing (including hereditary cancer and solid-tumor applications). Comparable to Informed Genomics on combining NGS and analytics for cancer diagnosis and personalized treatment, with broader European footprint.
  • Guardant Health: US-based liquid-biopsy and tissue genomics company (Guardant360, Guardant Reveal) focused on cancer diagnosis, treatment selection, and recurrence monitoring. Closest direct peer to Informed Genomics' "earlier diagnosis and personalized treatment" positioning for cancer.
  • Caris Life Sciences: Provides MI Profile molecular profiling and Caris Assure liquid biopsy for oncology. Directly competes with Informed Genomics on cancer genomic profiling and personalized treatment selection.

Regional players

  • Inivata: Cambridge, UK-based liquid biopsy company (acquired by NeoGenomics) focused on circulating tumor DNA for cancer treatment selection and monitoring. Closest geography-matched peer to Informed Genomics in the UK oncology genomics space.

Emerging players

  • Nonacus: UK-based genomics company providing NGS products and services for liquid biopsy and cancer research. Comparable to Informed Genomics as a UK-headquartered emerging player in cancer genomics, though more research-tools oriented.

Market position

Competitive moat1 record

Key highlights3 records

Customer concentration

Informed Genomics social profiles

Digital presence

Informed Genomics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Informed Genomics leadership team

Management profile

Number of profiles

Informed Genomics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Informed Genomics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Informed Genomics

What does Informed Genomics do?

Informed Genomics is a biotechnology company that provides genomics-based cancer diagnostics focused on earlier cancer diagnosis and the selection of personalized treatments. Its offering supports clinicians and patients in oncology by combining molecular and genomic testing to inform therapy decisions and improve clinical outcomes.

When was Informed Genomics founded?

Informed Genomics was founded in -1. It employs 11 to 50 people.

Where is Informed Genomics based?

Informed Genomics is headquartered in Birmingham, United Kingdom, in the Europe region.

Who are Informed Genomics's main competitors?

Broad incumbents on record are Exact Sciences (Genomic Health), Tempus Labs, Foundation Medicine and NeoGenomics. Direct peers are Personalis, SOPHiA Genetics, Guardant Health and Caris Life Sciences. Inivata is listed as a regional player. Nonacus is listed as an emerging player.

Does Informed Genomics have an API?

No public API is recorded for Informed Genomics.

What industry is Informed Genomics in?

Informed Genomics's product category is Cancer Genomics Diagnostics. Its primary akta.pro industry code is HLAAANAA, Genomic Profiling & Sequencing-Based Precision Medicine, with a secondary code of HLAFAMAE, Molecular Diagnostics & Genomics Laboratories. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales